GLP-1 formula for glucose control
Part of Hormones & metabolism clinical trials.
This trial tests whether a special GLP-1 formula can help regulate blood sugar and increase GLP-1 levels in people with higher body fat. It may offer a new way to support metabolic health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You have a body fat percentage greater than 25%.
- You haven't used probiotics, weight loss products, or gut health supplements in the last month.
- You do not have diabetes, autoimmune diseases, cancer, chronic gut problems, lactose intolerance, or chronic diarrhea.
- You have not had any stomach or intestinal surgery.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This trial tests a special drink that may help improve blood sugar levels and gut health in people with prediabetes. It could offer a simple way to manage blood sugar and potentially prevent diabetes.
This study compares how a GLP-1 medication (a drug that helps control blood sugar and weight) changes the way your body stores and uses fat. Researchers will use imaging scans to see these changes over time in people with metabolic syndrome—a cluster of health conditions including high blood pressure, high cholesterol, and excess weight.
This trial tests whether specific nutritional formulas can help people with type 2 diabetes keep their blood sugar levels in a healthy range more often, as measured by continuous glucose monitors.
This trial tests whether adding a GLP-1 receptor agonist (a medication that helps control blood sugar and appetite) after weight loss surgery improves outcomes for people with severe obesity and related health problems like type 2 diabetes.
This study tests whether a newer class of weight-loss medicines (GLP-1 and GIP/GLP-1 analogues) can help people with excess body weight eat healthier and improve their metabolism and behavior. It may be a good option if you are an adult with overweight or obesity and haven't used these medicines recently.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.